Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Setipiprant in partly controlled asthma
NCT01225315Phase 2Completed
- Sponsor
- Idorsia
- Start
- Nov 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of setipiprant in asthma, sponsored by Idorsia. Started Nov 2010; status: completed.
02
Drugs
setipiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01225315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225315.